Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. (PARD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PARD · as of Jun 9, 2026
Key Statistics
Explore Poniard Pharmaceuticals, Inc. Data
pard stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
pard competitorsPARD
AOLS
OZYMF
PXMD
QBIO
RCARStock Performance
Full HistoryAbout Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based th…
what is poniard pharmaceuticals, inc. · pard stock overview · poniard pharmaceuticals, inc. company profile · who is poniard pharmaceuticals, inc. ceo · pard OTC · poniard pharmaceuticals, inc. headquarters · poniard pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Poniard Pharmaceuticals, Inc. (PARD) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 11, 1988. As of the latest trading session, PARD stock price is $0.00, with a market capitalization of $150. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2010, Poniard Pharmaceuticals, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Poniard Pharmaceuticals, Inc. (PARD) stock price is $0.00. The stock is traded on OTC under the ticker symbol PARD. The 52-week range is $0.00 – $0.00.